Table 2 Multivariate Cox-regression models for OS in patients with t(6;9)(p22;q34).

From: Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases

Patient group

Prognostic factors

Hazard ratio (95% CI)

p value

All patients (n = 60)

   
 

MDS vs. AML

0.45 (0.24–0.81)

0.008

 

Transplantation

0.20 (0.11–0.36)

<0.0001

Patients without transplantation (n = 29)

   
 

MDS vs. AML

0.24 (0.09–0.64)

0.005

 

Age (>60 years)

3.13 (1.37–7.14)

0.007

  1. OS overall survival, CI confidence interval, MDS myelodysplastic syndrome, AML acute myeloid leukemia.
Back to article page